Profen and Vanishing bile duct syndrome - a phase IV clinical study of FDA data
Vanishing bile duct syndrome is found among people who take Profen, especially for people who are male, 20-29 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Profen and have Vanishing bile duct syndrome. It is created by eHealthMe based on reports of 204,671 people who have side effects when taking Profen from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
204,671 people reported to have side effects when taking Profen.
Among them, 156 people (0.08%) have Vanishing bile duct syndrome.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 190,060 Profen users for its effectiveness, alternative drugs and more.
What is Vanishing bile duct syndrome?
Vanishing bile duct syndrome (loose collection of diseases which leads to the injury to hepatic bile ducts and eventual ductopenia) is found to be associated with 227 drugs and 168 conditions by eHealthMe.
Number of Profen and Vanishing bile duct syndrome reports submitted per year:
Time on Profen when people have Vanishing bile duct syndrome *:
Gender of people who have Vanishing bile duct syndrome when taking Profen*:
Age of people who have Vanishing bile duct syndrome when taking Profen *:
Common drugs people take besides Profen *:
Common side effects people have besides Vanishing bile duct syndrome *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Profen and have Vanishing bile duct syndrome?Check whether Vanishing bile duct syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How severe was Vanishing bile duct syndrome and when was it recovered:
Expand to all the drugs that have ingredients of ibuprofen:
Alternative drugs to, pros and cons of Profen:
- Profen (190,060 reports)
Common Profen side effects:
Browse all side effects of Profen:a b c d e f g h i j k l m n o p q r s t u v w x y z
Vanishing bile duct syndrome treatments and more:
- Vanishing bile duct syndrome (881 reports)
COVID vaccines that are related to Vanishing bile duct syndrome:
- Vanishing bile duct syndrome in Moderna COVID Vaccine
- Vanishing bile duct syndrome in Pfizer BioNTech Covid Vaccine
- Vanishing bile duct syndrome in Johnson and Johnson Covid Vaccine
Common drugs associated with Vanishing bile duct syndrome:
All the drugs that are associated with Vanishing bile duct syndrome:
- Vanishing bile duct syndrome (227 drugs)
All the conditions that are associated with Vanishing bile duct syndrome:
- Vanishing bile duct syndrome (168 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Profen) and Profen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tryptophan and Appetite - Decreased - now
- Tryptophan and Appetite Decreased - a second ago
- Alvesco and Nadolol drug interaction - 6 seconds ago
- Calcium Carbonate and Sunosi drug interaction - 16 seconds ago
- Lucentis and Ligament Sprain - 17 seconds ago
- Enlarged Prostate and Paradoxical Drug Reaction - 22 seconds ago
- Carafate and Calan drug interaction - 22 seconds ago
- Seng and Pain - 28 seconds ago
- Nicotine and Eye Injury - 28 seconds ago
- Fentanyl-25 vs. Lorazepam - 32 seconds ago